S3A Guidance: Note for Guidance on Toxicokinetics: The Assessment of Systemic Exposure in Toxicity Studies: Focus on Microsampling
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 9, 2018
April 17, 2020
9ffd98db-d7b4-4ab7-a1b8-146abe8b400e
Related Documents
Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Questions and Answers Guidance for Industry
Guidance DocumentApril 20, 2018Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances--Questions and Answers (Chemical Entities and Biotechnological/Biological Entities)
Guidance DocumentFebruary 26, 2018Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.